Clinical Evaluation of Medicated Bathing Agent Eaudeleman in Patients with Atopic Dermatitis:Clinical Research Group of Medicated Bathing Agent Eaudeleman

Tetsuro Sugai, Junko Katoh, Toshio Hamada, Kazunobu Mochida, Hirokazu Yasuno, Kiyoshi Kagami, Ritsuko Hayakawa, Mari Suzuki, Yasuko Ogino, Hiroshi Ueda, Kayoko Matsunaga

Research output: Contribution to journalArticle

Abstract

Clinical evaluation of medicated bathing agent “Eaudeleman” is made in 67 patients with atopic dermatitis and 26 patients with asteatotic dermatitis for 4 weeks in a multicenter open trial study. In addition, 59 patients with atopic dermatitis and 25 patients with asteatotic dermatitis are also evaluated as a control group. No significant difference was found between the test group and the control group in the both diseases. The final global improvement rating was 65.7% (44/67) at the test group and 71.2% (43/59) at the control group in more than slight improvement in atopic patients, while it was 100.0% (26/26) at the test group and 88.0% (22/25) at the control group in asteatotic patients. The side effects were seen seven in patients with atopic dermatitis, and none in patients with asteatotic dermatitis.

Original languageEnglish
Pages (from-to)867-874
Number of pages8
Journalskin research
Volume36
Issue number6
DOIs
Publication statusPublished - 1994

All Science Journal Classification (ASJC) codes

  • Dermatology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Clinical Evaluation of Medicated Bathing Agent Eaudeleman in Patients with Atopic Dermatitis:Clinical Research Group of Medicated Bathing Agent Eaudeleman'. Together they form a unique fingerprint.

Cite this